Target intelligence / Profile preview

Fungal melanin biosynthesis pathway (DHN/DOPA pathway)

Target
DHN/DOPA pathway
Molecular classification
Enzyme, Metabolic pathway
01

Overview

The fungal melanin biosynthesis pathway is a critical metabolic route responsible for the production of melanin, a high-molecular-weight pigment essential for fungal survival and pathogenicity [Henson et al., 1999]. In most filamentous fungi, melanin is synthesized via the 1,8-dihydroxynaphthalene (DHN) pathway, while certain yeasts like Cryptococcus neoformans utilize the L-3,4-dihydroxyphenylalanine (DOPA) pathway [Langfelder et al., 2003]. Melanin functions as a biological shield, protecting the fungus from environmental insults such as ultraviolet (UV) radiation, extreme temperatures, and oxidative stress [Nosanchuk & Casadevall, 2003]. Within a host, melanin acts as a potent virulence factor by neutralizing reactive oxygen species produced by immune cells and masking fungal components to evade detection [Upadhyay et al., 2023]. Pharmacological inhibition of this pathway, primarily through melanin biosynthesis inhibitors (MBIs) like tricyclazole, disrupts the formation of the protective pigment, thereby reducing the fungus's ability to infect hosts and survive environmental stress [Henson et al., 1999]. While currently most prevalent in agricultural applications to combat rice blast, this pathway represents a promising target for developing novel clinical antifungals that attenuate virulence rather than directly killing the organism.

Other names
DHN-melanin pathwayDOPA-melanin pathwayFungal melanogenesisPolyketide-derived melanin pathway
02

Mechanism of action

Inhibition of specific enzymes within the melanin biosynthetic route, such as 1,3,8-trihydroxynaphthalene reductase (3HNR) or scytalone dehydratase (SDH), which prevents the polymerization of 1,8-dihydroxynaphthalene into melanin [Henson et al., 1999; Upadhyay et al., 2023].

03

Biological functions

Protection against UV radiationOxidative stress resistanceCell wall integrityVirulence factorHost immune evasion
04

Disease associations

InfectionFungal keratitisCryptococcosisAspergillosisRice blast disease
05

Safety considerations

Potential for environmental toxicityLimited efficacy as monotherapy in systemic human infectionsSpecies-specific pathway variationsPotential cross-reactivity with human melanogenesis (for DOPA pathway inhibitors) [Nosanchuk & Casadevall, 2003]
06

Interacting drugs

Tricyclazole

5 more in the full profile.

07

Biomarkers

Fungal pigmentation (conidial color)Scytalone accumulation1,3,8-trihydroxynaphthalene levelsLaccase activity

Beyond the preview

Go deeper on Fungal melanin biosynthesis pathway (DHN/DOPA pathway).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fungal melanin biosynthesis pathway (DHN/DOPA pathway).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call